Home › Calculator › TCRT Dividend Calculator 2026
TCRT Dividend DRIP Calculator 2026
100.50% YieldHealthcareAlaunos Therapeutics, Inc. · NASDAQ
Price: $1.99 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When TCRT pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your TCRT snowball 📈
$10,000 in TCRT → $10.50M in 10 years · $438,605.47/month
About Alaunos Therapeutics, Inc. (TCRT) — Dividend Analysis 2026
Alaunos Therapeutics, Inc. is an oncology company in the clinical trial phase, specializing in the creation of adoptive T-cell receptor (TCR) engineered therapies. Their pipeline includes a TCR Library, currently undergoing Phase I/II clinical trials, which comprises ten T-cell receptors designed to target mutated KRAS, TP53, and EGFR in various cancers such as non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers. Additionally, they are advancing hunTR, a platform focused on human neoantigen T-cell receptors, and mbIL-15, intended for solid tumor treatment. The company maintains strategic collaborations, including a licensing agreement with PGEN Therapeutics, Inc., a research and development partnership with The University of Texas MD Anderson Cancer Center, and both a patent licensing and R&D agreement with the National Cancer Institute. Previously known as ZIOPHARM Oncology, Inc., the company adopted its current name, Alaunos Therapeutics, Inc., in January 2022. Its headquarters are located in Houston, Texas.
Compare TCRT with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full TCRT DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open TCRT position with:
🌍 TCRT Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold TCRT.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 100.50% | 97.70% | $10,050 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 85.42% | 82.63% | $8,543 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 80.40% | 77.60% | $8,040 / yr |
| 🇬🇧 UK ISA | 0% | 100.50% | 97.70% | $10,050 / yr |
| 🇬🇧 UK Taxable | 8.75% | 91.71% | 88.91% | $9,171 / yr |
| 🇨🇦 TFSA | 0% | 100.50% | 97.70% | $10,050 / yr |
| 🇨🇦 CA Taxable | 25% | 75.38% | 72.58% | $7,538 / yr |
| 🇦🇺 Super (pension) | 15% | 85.42% | 82.63% | $8,543 / yr |
| 🇦🇺 AU Taxable | 30% | 70.35% | 67.55% | $7,035 / yr |
| 🇩🇪 DE Taxable | 26.375% | 73.99% | 71.19% | $7,399 / yr |
| 🇫🇷 FR Taxable | 30% | 70.35% | 67.55% | $7,035 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 TCRT Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 TCRT Dividend Payment Schedule
TCRT pays quarterly — 4 times per year. Next ex-div: TBD.
📊 TCRT vs Healthcare Benchmarks
How TCRT compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for TCRT sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ TCRT Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-08-06 | 4,363 | $2.01 | $8.8K | ||
| A-Award | 2026-07-23 | 8,138 | $1.92 | $15.6K | ||
| A-Award | 2026-07-23 | 4,568 | $1.92 | $8.8K | ||
| A-Award | 2026-07-23 | 8,463 | $1.92 | $16.2K | ||
| A-Award | 2026-07-23 | 8,789 | $1.92 | $16.9K | ||
| A-Award | 2026-06-30 | 3,880 | $2.26 | $8.8K | ||
| A-Award | 2026-06-12 | 7,761 | $2.26 | $17.5K | ||
| A-Award | 2026-05-22 | 3,700 | $2.37 | $8.8K | ||
| A-Award | 2026-04-29 | 6,515 | $2.59 | $16.9K | ||
| A-Award | 2026-04-29 | 6,274 | $2.59 | $16.3K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the TCRT dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Alaunos Therapeutics, Inc. (TCRT) is currently trading at $1.99, 100% below its 52-week high. The current dividend yield is 100.50% based on an annual payout of $2.00 per share.
TCRT (Alaunos Therapeutics, Inc.) — 100.50% Dividend Yield Analysis
Alaunos Therapeutics, Inc. (TCRT) is a healthcare stock currently trading at $1.99 with a dividend yield of 100.50%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (100.50%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.